We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Infectious Disease Panel Expanded to Include STD

By LabMedica International staff writers
Posted on 09 Aug 2010
Target Enriched Multiplex Polymerase Chain Reaction (TEM-PCR) allows the quick and accurate detection of many communicable diseases. More...


A sexually transmitted disease (STD) panel and a Herpes Simplex Virus (HSV) panel are now available that are highly sensitive with rapid response diagnostic capabilities. The STD panel identifies 10 sexually transmitted diseases simultaneously, and the HSV panel identifies herpes simplex viruses 1 and 2.

TEM-PCR is the first diagnostic technology introduced to the clinical market that can identify multiple pathogens, both viral and bacterial, detect coinfections and highly transferable genetic antibiotic resistances simultaneously. The two panels are manufactured by DIATHERIX Laboratories, (Huntsville, AL, USA) using the company's proprietary TEM-PCR technology. The STD panel tests for the following organisms: Atopobium vaginae, Chlamydia trachomatis, Gardnerella vaginalis, Haemophilus ducreyi, Mycoplasma hominis, Mycoplasma genitalium, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, and Ureaplasma urealyticum.

Dennis Grimaud, chairman and CEO of DIATHERIX, Inc., said, "This STD Panel will return accurate results the same day the specimen is received, providing appropriate diagnosis and therapy resulting in a reduction in the improper utilization of antibiotics." The company states that their test panel identifies more STD organisms in one sample than any other commercially available test on the market. Healthcare providers now have the option to select both the STD and HSV panel as they can test for a total of twelve pathogens at the same time.

These STD organisms, if not appropriately treated, can cause diseases such as syphilis, gonorrhea, Chlamydial infection, bacterial vaginosis, and may lead to blindness, infertility, or complications during pregnancy. The U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), estimates there are approximately 19 million new STD cases each year.

Related Links:

Diatherix Inc.
CDC




Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
Mini Vortex Mixer
Vornado
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.